Effects of ranibizumab and zoledronic acid on endometriosis in a rat model
Author:
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00404-021-06104-9.pdf
Reference30 articles.
1. Sourial S, Tempest N, Hapangama DK (2014) Theories on the pathogenesis of endometriosis. Int J Reprod Med 2014:179515. https://doi.org/10.1155/2014/179515
2. Zhou WJ, Yang HL, Shao J, Mei J, Chang KK, Zhu R, Li MQ (2019) Anti-inflammatory cytokines in endometriosis. Cell Mol Life Sci 76(11):2111–2132. https://doi.org/10.1007/s00018-019-03056-x
3. Onalan G, Tohma YA, Zeyneloglu HB (2018) Effect of etanercept on the success of assisted reproductive technology in patients with endometrioma. Gynecol Obstet Invest 83(4):358–364. https://doi.org/10.1159/000484895
4. Dull AM, Moga MA, Dimienescu OG, Sechel G, Burtea V, Anastasiu CV (2019) Therapeutic approaches of resveratrol on endometriosis via anti-inflammatory and anti-angiogenic pathways. Molecules. https://doi.org/10.3390/molecules24040667
5. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431. https://doi.org/10.1056/NEJMoa054481
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. El efecto del agente antiangiogénico aflibercept sobre la endometriosis inducida quirúrgicamente en un modelo de rata;Cirugía y Cirujanos;2024-03-12
2. Angiogenesis signaling in endometriosis: Molecules, diagnosis and treatment (Review);Molecular Medicine Reports;2024-01-18
3. Concerns on ranibizumab and zoledronic acid safety for experimentally treating women with endometriosis;Archives of Gynecology and Obstetrics;2022-01-06
4. Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis;World Journal of Meta-Analysis;2021-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3